CSF2 and congenital rubella syndrome: In addition to CRS, GM-CSF further exacerbates the neurotoxicity of CAR-T therapy by promoting the migration of inflammatory phagocytes to the central nervous system (CNS) and releasing reactive oxygen species and inflammatory cytokines.